Osel Launches Phase 2b Trial for Preterm Birth Prevention
MOUNTAIN VIEW, Calif., ARLINGTON, Va., and LONDON, England, May 13, 2026 Osel Inc., in partnership with March of Dimes...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
MOUNTAIN VIEW, Calif., ARLINGTON, Va., and LONDON, England, May 13, 2026 Osel Inc., in partnership with March of Dimes...
NEW YORK, Feb. 2, 2026 — CD Genomics announced the launch of its Microbial Single-Cell Sequencing Service, positioning the...
